In November, the company announced its intentions to begin selling generic liraglutide, another GLP-1 from Novo thats been on the market since 2010, in the coming months
Gilman CP, Perry T, Furukawa K et al (2003) Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons
It's 'at what point does continued benefit justify continued injections.' For most patients, that threshold is around six months of active use
According to MyFitnessPal, this is an extremely health-motivated segment on the platform, and as GLP-1 adoption continues to grow, that engagement is the signal worth paying attention to.
For cancer cells lacking upregulated EAAT3, it is plausible that other glutamate transporter systems are elevated, and further investigation is required to confirm this
Patients typically report feeling fuller for longer periods and experiencing reduced food cravings